InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Meowza post# 266673

Thursday, 04/16/2020 11:22:00 AM

Thursday, April 16, 2020 11:22:00 AM

Post# of 423842
M-

No question, the conclusion is wrong … I would like to find the "reason" * why it happened. What is your thought about this part:

"statistically-significant differential effects": it is true … "EPA" arm vas SS, placebo was not (it was NS) … these effects (statistically) were different.

Best,
G

* ps.: to make it clear / avoid any doubt

Meanwhile I expected an ANCHOR approval in Oct 2013, I accepted / saw the reason - shortly after the decision - behind the FDA decision (SPA) … a lot of posters called me a moron … some of them is still way-off.
In this case - especially in light of Hamoa finding about Kurabayashi - I still could not see the reason behind the decsion … other than it was an error

Excuse me for cluttering board with theories that are off point … :-)

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News